Back to NB Norinchukin Bank, The
REGN
Showing 8 of 28 quarters
Position history for NBNorinchukin Bank, The's holdings in Regeneron Pharmaceuticals, Inc.
Yes. Norinchukin Bank, The holds 10,061 shares of REGN (Regeneron Pharmaceuticals), worth $7.6M, as of its Q3 2026 13F filing. It increased the position by 227 shares (+2.3%) from Q2 2026. Norinchukin Bank, The has listed REGN in each of its last 28 quarterly 13F filings. REGN is 0.1% of Norinchukin Bank, The's reported 13F portfolio.
Current Value
$7.6M
Current Shares
10,061
Total Value Change
+$3.5M
Total Shares Change
+4,251
Quarter-by-Quarter History
Other major holders of REGN: FMR LLC, Vanguard Group Inc.